Hugel

formerly Hugel PharmaIPO

Power That Makes You Shine

Public · Chuncheon, South Korea · Founded 2001 · $831.0M raised

Headquarters
Chuncheon
Employees
201–500
Founded
2001
Business Model
B2B
Total Funding
$831.0M
Last Round
$831.0M Private EquityJun 2017
Rounds
1
Type
Public
Ticker
145020 · KRX

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Hugel is a South Korean global leader in medical aesthetics founded in 2001, producing botulinum toxin (Botulax/Letybo), hyaluronic acid fillers, skin boosters, threads, and bio-cosmetics. Present in over 70 countries, Hugel received US FDA approval for Letybo in 2024, challenging established neurotoxin brands. The company serves healthcare professionals worldwide through academic programs and maintains strict international quality and manufacturing standards.

Summary

Hugel is a Biotech company based in Chuncheon, South Korea, founded in 2001. It has raised $831.0M in total across 1 round, most recently a $831.0M Private Equity round in Jun 2017. Investors include CBC Group, GS Group and Bain Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketMajority Stake SaleAug 2021

Sign up to see all 2 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hugel on Indexed.vc
<a href="https://indexed.vc/companies/hugel"><img src="https://indexed.vc/api/badge/company/hugel" alt="Hugel on Indexed.vc" width="260" height="76" /></a>